Ontology highlight
ABSTRACT: Introduction
Omidubicel, an advanced cell therapy used for allogeneic hematopoietic stem cell transplant has demonstrated faster hematopoietic recovery, shorter hospitalization, and lower rates of bacterial, viral, and invasive fungal infections compared with umbilical cord blood (UCB) in a phase III randomized trial (NCT02730299;Blood 2021;138:1429). Objective
The objective was to compare changes in health-related quality of life (HRQL) between treatment groups in the phase III trial. Methods
Patients who received protocol-defined treatment and provided HRQL evaluations at baseline and ≥1 follow-up visit were analyzed. Outcomes included Functional Assessment of Cancer Therapy General (FACT-G) domain scores for physical, social/family, functional and emo
SUBMITTER:
PROVIDER: S-EPMC9446902 | biostudies-literature | 2022 Sep
REPOSITORIES: biostudies-literature